Cyclerion Therapeutics, Inc.
CYCNDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Frequently asked questions
What is in Cyclerion Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Cyclerion Therapeutics, Inc.'s (CYCN) pipeline across Phase 2. Its lead program is IW-1701 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Cyclerion Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Cyclerion Therapeutics, Inc. (CYCN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CYCN biotech catalysts?→
Add CYCN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Cyclerion Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.